Barclays »

Eliem Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $351k 27k 13.04
2026-03-31 $335k 49k 6.85
2025-12-31 $247k 62k 4.00
2025-09-30 $50k 25k 2.01
2025-06-30 $37k 29k 1.26
2025-03-31 $72k 59k 1.23
2024-12-31 $89k 50k 1.79
2024-09-30 $198k 39k 5.10
2024-06-30 $18k 2.5k 7.08
2022-03-31 $24k 2.9k 8.42